Table 2 |
|||
|
Prediction of pathological complete remission without Ki67, using multiple linear regression analysis (final model) |
|||
|
Characteristic |
OR |
95% CI |
P |
|
|
|||
|
pT |
|||
|
1 |
1 |
- |
- |
|
2-4 |
0.39 |
0.21-0.73 |
< 0.01 |
|
Grading |
|||
|
1-2 |
1 |
- |
- |
|
3 |
2.95 |
1.67-5.24 |
< 0.001 |
|
Estrogen receptor status |
|||
|
Negative |
1 |
- |
- |
|
Positive |
0.28 |
0.13-0.57 |
< 0.001 |
|
Progesterone receptor status |
|||
|
Negative |
1 |
- |
- |
|
Positive |
0.42 |
0.19-0.92 |
0.03 |
|
HER2/neu receptor status |
|||
|
Negative |
1 |
- |
- |
|
Positive |
2.42 |
1.36-4.32 |
< 0.01 |
|
|
|||
|
CI, confidence intervals; OR, odds ratio; pT, pathological tumor stage (TNM classification). |
|||
|
Fasching et al. BMC Cancer 2011 11:486 doi:10.1186/1471-2407-11-486 |
|||
